SEARCH

SEARCH BY CITATION

References

  • 1
    Adjaye, N., Bain, B.J. & Steer, P. (1989) Prediction and diagnosis of sickling disorders in neonates. Archives of Diseases in Childhood, 64, 3943.
  • 2
    Akinyanju, O.O. (1989) A profile of sickle cell disease in Nigeria. Annals of the New York Academy of Sciences, 565, 126136.
  • 3
    Angastiniotis, M.A. & Hadjiminas, M.G. (1981) Prevention of thalassaemia in Cyprus. Lancet, i, 369371.DOI: 10.1016/S0140-6736(81)91682-2
  • 4
    Barton, C. & Watson, A. (1988) Neonatal screening for haemoglobinopathies. British Medical Journal, 297, 200.
  • 5
    Brozovic, M. & Stephens, A. (1991) Guidelines for the Management of Sickle Cell Disease. Unpublished W.H.O. document WHO/HDP/SCD/GL/91.2 Hereditary Diseases Programme. W.H.O., Geneva.
  • 6
    Buckley, M.E., Brassington, P.E. & Long, M.J. (1975) Abnormal haemoglobins in South-East Staffordshire. Lancet, ii, 82.
  • 7
    Calman, K. (1994) Developing screening in the NHS. Journal of Medical Screening, 1, 101105.
  • 8
    Cao, A., Rosatelli, C. & Galanello, R. (1989) The prevention of thalassaemia in Sardinia. Clinical Genetics, 36, 277285.
  • 9
    Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. New England Journal of Medicine, 332, 13171322.
  • 10
    Cook, A.I. & Lehmann, H. (1972) Beta thalassaemia and some rare haemoglobin variants in the highlands of Scotland. Scottish Medical Journal, 18, 1420.
  • 11
    Cronin, E.K., Normand, C., Hickman, M. & Davies, S.C. (1998) Neonatal screening of haemoglobinopathies: costs and cost-effectiveness of neonatal screening. Archives of Diseases in Childhood, 79, F161F167.
  • 12
    Darr, A. & Modell, B. (1988) The frequency of consanguineous marriage among British Pakistanis. Journal of Medical Genetics, 25, 186190.
  • 13
    (Day Report) Report of a Working Group (1996) The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995–1999: projections using data to the end of 1994. CDR Review, 6(1), R1–R24 (see Table 7, pR10).
  • 14
    Davies, S. (1993) Services for people with haemoglobinopathy. British Medical Journal, 308, 10511052.
  • 15
    Davies, S.C. & Oni, L. (1997) Management of patients with sickle cell disease. British Medical Journal, 315, 656660.
  • 16
    Department of Health (1993) Report of a Working Party of the Standing Medical Advisory Committee on Sickle Cell, Thalassaemia, and other Haemoglobinopathies. H.M.S.O., London.
  • 17
    Fleming, A.F. (ed.) (1992) Epidemiology of haematological diseases: part II. Bailliere's Clinical Haematology, 5(2), 331365.
  • 18
    Fleming, A., Storey, L., Molineaux, S., Iroko, E. & Attai, E. (1979) Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Annals of Tropical Medicine and Parasitology, 73, 161172.
  • 19
    Gaston, M.H., Verter, J.I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J.S., Diamond, S., Holbrook, T., Gill, F.M., Ritchey, K. & Falletta, J.M. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. New England Journal of Medicine, 314, 15931599.
  • 20
    Greengross, P., Hickmans, M., Gills, M., Dugans, B. & Daviess, S.C. (1998) Outcomes of universal antenatal screening for the haemoglobinopathies. Journal of Medical Screening (in press).
  • 21
    Health Education Authority (HEA) (1988) Sickle Cell and Thalassaemia: Achieving Health Gain: Guidance for Commissioners and Providers. HEA, London.
  • 22
    Henthorn, J., Anionwu, E. & Brozovic, M. (1984) Screening cord blood for sickle haemoglobinopathies in Brent. British Medical Journal, 289, 479480.
  • 23
    Hereditary Diseases Programme, W.H.O. (1994) Guidelines for the Control of Haemoglobin Disorders. Unpublished WHO document WHO/HDP/G/94.1. W.H.O., Geneva.
  • 24
    Horn, M., Dick, M., Frost, B., Davis, L.R., Bellingham, A.J., Stroud, C.E. & Studd, J.W. (1986) Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two-year pilot study. British Medical Journal, 292, 737740.
  • 25
    Knox-MacAulay, H.H.M., Weatherall, D.J., Clegg, J.B. & Pembrey, M.E. (1973) Thalassaemia in the British. British Medical Journal, iii, 150.
  • 26
    Livingstone, F.A. (1985) Frequencies of Haemoglobin Variants. Oxford University Press.
  • 27
    Lorey, F., Cunningham, G., Shafer, F., Lubin, B. & Vichinsky, E. (1994) Universal screening for haemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. European Journal of Human Genetics, 2, 262271.
  • 28
    Modell, B. (1993) Concerted action on developing patient registers as a tool for improving service delivery for haemoglobin disorders. In: Health Services Research (ed. by G. N. Fracchia and M. Theophilatou). IOS Press, Amsterdam.
  • 29
    Modell, B. & Anionwu, E.N. (1996) Guidelines for screening for haemoglobin disorders: services specifications for low and high prevalence DHAs. Ethnicity and Health: Reviews of Literature and Guidance for Purchasers in the Areas of Cardiovascular Disease, Mental Health and Haemoglobinopathies, pp. 127–224. York: University of York, NHS Centre for Reviews and Dissemination. CRD Report 5, Part 4.
  • 30
    Modell, B. & Berdoukas, V. (1984) The Clinical Approach to Thalassemia. Grune & Stratton, New York.
  • 31
    Modell, B. & Bulyzhenkov, V. (1988) Distribution and control of some genetic disorders. World Health Statistical Quarterly, 41, 209218.
  • 32
    Modell, B., Kuliev, A.M. & Wagner, M. (1992) Community Genetics Services in Europe. W.H.O. Regional Publications, European Series No. 38, W.H.O. Regional Office for Europe, Copenhagen.
  • 33
    Modell, B., Letsky, E.A., Flynn, D.M., Peto, R. & Weatherall, D.J. (1982) Survival and desferrioxamine in thalassaemia major. British Medical Journal, 284, 10811084.
  • 34
    Modell, B. & Petrou, M. (1983) Management of thalassaemia major. Archives of Diseases in Childhood, 58, 10261030.
  • 35
    National Screening Committee (1998) First report of the National Screening Committee. Department of Health.
  • 36
    Ohene-Frempong, K. & Nkrumah, F.K. (1994) Sickle cell disease in Africa. Sickle Cell Disease: Basic Principles and Clinical Practice (ed. by S. H. Embury, N. M. Hebble, N. Mohandas, M. H. Steinberg), pp. 423–435. Raven Press, New York.
  • 37
    OPCS (1993) Revised final mid-1991 population estimates for England and Wales and constituent local and health authorities based on 1991 Census results. PP1 93/2.
  • 38
    OPCS and GRO Scotland (1993) 1991 Census: Ethnic Group and Country of Birth in Great Britain.
  • 39
    Petrou, M., Brugiatelli, M., Old, J., Hurley, P., Ward, R.H., Wong, K.P., Rodeck, C. & Modell, B. (1992) Alpha thalassaemia hydrops fetalis in the UK: the importance of screening pregnant women of Chinese, other South East Asian, and Mediterranean extraction for alpha thalassaemia trait. British Journal of Obstetrics and Gynaecology, 99, 985989.
  • 40
    Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease: life expectancy and risk factors for early death. New England Journal of Medicine, 330, 16391643.DOI: 10.1056/NEJM199406093302303
  • 41
    Serjeant, G.R., Serjeant, B.E., Forbes, M., Hayes, R.J., Higgs, D.R. & Lehmann, H. (1986) Haemoglobin gene frequencies in the Jamaican population: a study of 100,000 newborns. British Journal of Haematology, 64, 253262.
  • 42
    Sickle Cell Disease Guideline Panel (1993) Sickle Cell Disease: Screening, Diagnosis, Management, and Counselling in Newborns and Infants. Clinical Practice Guideline 6. U.S. Department of Health and Human Sciences, Rockville, Maryland.
  • 43
    Silvestroni, E., Bianco, I., Graziani, B., Carboni, C. & D'Arca, S.U. (1968) First premarital screening of thalassaemia carriers in intermediate schools in Latium. Journal of Medical Genetics, 15, 202207.
  • 44
    Streetly, A., Dick, M. & Layton, M. (1993) Sickle cell disease: the case for coordinated information. British Medical Journal, 306, 14911492.
  • 45
    Sukumaran, P.K. & Master, H.R. (1974) The distribution of abnormal haemoglobin in the Indian population. Proceedings of 1st Conference of the Indian Society of Human Genetics, Vol. 1. Human Population Genetics in India, pp. 91–111. Orient Longman, Bombay.
  • 46
    Thalassaemia Working Party of the BCSH General Haematology Task Force (1994) Guidelines for investigation of the α and β thalassaemia traits. Journal of Clinical Pathology, 47, 289295.
  • 47
    Tillyer, M.L., Varawalla, N.Y., Tiller, C.R., Sandhu, P. & Modell, B. (1993) Thalassaemia, abnormal haemoglobins, and iron deficiency in a British Asian population. Clinical and Laboratory Haematology, 15, 157164.
  • 48
    U.S. Department of Health and Human Services (1993) Sickle Cell Disease: screening, diagnosis, management, and counselling in newborns and infants: Clinical Practice Guideline.
  • 49
    U.S. Preventive Services Task Force (1989) Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. William & Wilkins, Baltimore.
  • 50
    W.H.O. (1985) Update of the Progress of Haemoglobinopathies Control. Report of the W.H.O. Working Group for the Community Control of Hereditary Anaemias. Unpublished W.H.O. report HMG/WG/85.8 Hereditary Disease Programme. W.H.O., Geneva.
  • 51
    W.H.O. (1987) The Haemoglobinopathies in Europe. W.H.O. Regional Office for Europe, IPC/MCH 110. Maternal and Child Health Division. WHO Regional Office for Europe, Copenhagen.
  • 52
    W.H.O. (1988) The Haemoglobinopathies in Europe. A Report on Two W.H.O. Meetings. W.H.O. Regional Office for Europe, Copenhagen.
  • 53
    Wilson, J.M.G. & Jungner, G. (1968) Principles and Practice of Screening for Disease. World Health Organization, Geneva.
  • 54
    Zang, B.H. (1986) Screening of Hb Barts in cord blood from Guangxi province and its alpha globin gene analysis. Acta Academia Medica Sinicae, 8, 165171.
  • 55
    Zeuner, D., Ades, A.E., Karnon, J., Brown, J., Dezateux, C. & Anionwu, E.N. (1999) Antenatal and neonatal haemoglobinopathy screening in the U.K.: review and economic analysis. The Health Technology Assessment Panel, NHS Executive, Leeds.
  • 56
    Zeng, Y.T. (1981) Hemoglobinopathies in mainland China. Hemoglobin, 5, 517524.
  • 57
    Zurlo, M.G., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Piga, A., Melevendi, C., Di Gregorio, F., Burattini, M.G. & Terzoli, S. (1989) Survival and causes of death in thalassaemia major. Lancet, i, 2730.DOI: 10.1016/S0140-6736(89)90264-X